With the FDA showing once again that it is willing to ignore the recommendations of its own panels, investors in MELA Sciences ([[MELA]] +3.7%) will have some nervous days ahead of a final decision on the MelaFind, as the FDA clearly had concerns with this application.
With the FDA showing once again that it is willing to ignore the recommendations of its own...
Recommended For You
About SSKN Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
SSKN | - | - |
STRATA Skin Sciences, Inc. |